| Financial Year |
March 31 2023 |
| Monetary Funds |
14,421,982,519.54 |
| Held-for-trading Financial Assets |
1,012,161,255.29 |
| Notes Receivable |
-- |
| Accounts Receivable |
1,274,819,277.75 |
| Advances to Suppliers |
426,014,624.05 |
| Other Receivables |
995,807,736.17 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
4,527,296,459.95 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
8,533,218.70 |
| Other Current Assets |
502,320,816.65 |
| Total Current Assets |
24,226,909,004.26 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
63,450,075.13 |
| Long-term Equity Investment |
41,080,600.07 |
| Investment Properties |
-- |
| Fixed Assetes |
8,917,824,674.55 |
| Under-construction Projects |
406,265,264.06 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
6,956,742,261.94 |
| R&D expenses |
1,574,433,520.48 |
| Goodwill |
65,011,991.71 |
| Long-Term Deferred and Prepaid Expenses |
151,691,307.47 |
| Deferred Income Tax Assets |
131,640,965.94 |
| Other Non-Current Assets |
1,272,674,503.74 |
| Sub-Total of Non-Current Assets |
20,170,805,458.98 |
| Total Assets |
44,397,714,463.24 |
| Short-Term Loans |
2,866,012,119.44 |
| Trading Financial liabilities |
-- |
| Notes Payable |
15,284,943,154.57 |
| Accounts Payable |
7,901,374,127.04 |
| Accounts Received In Advance |
1,145,495.99 |
| Employee Compensation Payable |
257,095,601.24 |
| Taxes Payable |
182,992,401.52 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,133,102,090.25 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,117,960,983.02 |
| Other Current Liabilities |
69,247,704.65 |
| Sub-Total of Current Liabilities |
29,448,548,716.44 |
| Long-term Loans |
2,336,569,739.29 |
| Bonds Payable |
149,922,679.95 |
| Long-Term Accounts Payable |
1,174,695,890.41 |
| Special Payable |
-- |
| Estimatied Liabilities |
42,416,517.73 |
| Deferred Income Tax Liabilities |
49,075,313.67 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
6,036,858,289.48 |
| Total Liabilities |
35,485,407,005.92 |
| Paid-In Capital(Or Share Stock) |
1,497,283,184.00 |
| Capital Surplus |
15,302,892,878.12 |
| Surplus Reserve |
358,078,946.41 |
| LESS:Treasury Stock |
99,991,090.70 |
| Undistributed Profits |
-6,229,313,369.31 |
| Minority Stockholder's Interest |
-1,882,374,547.56 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
10,794,682,004.88 |
| Owner's Equity（Stockholder's Equity） |
8,912,307,457.32 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
44,397,714,463.24 |
